Press release
Key Trends Shaping the Future Biosimilar Therapeutic Peptides Market From 2025-2034: Fujitsu Launches Biodrug Design Accelerator Platform To Revolutionize Peptide Drug Discovery
Biosimilar Therapeutic Peptides Market Size
In recent years, the market size for biosimilar therapeutic peptides has seen an explosive growth. It is expected to expand from $2.06 billion in 2024 to $2.68 billion in 2025, reflecting a compound annual growth rate (CAGR) of 30.3%. The surge during this past period can be linked to factors such as heightened demand for economically viable therapeutics, conducive regulatory structures and support, the expiration of patents on biologic drugs, a growing incidence of chronic diseases, and robust manufacturing processes.
The market for biosimilar therapeutic peptides is projected to experience substantial growth in the coming years, reaching $4.87 billion by 2029 with an annual growth rate of 16.1%. Reasons for this projected growth include the broadening of therapeutic applications, the aging worldwide population, a competitive market landscape, strategic collaborations and partnerships, and the patient inclination towards non-invasive treatments. The forecast period will also see significant trends such as advancements in biotechnology, a growing demand for biological products, technological revolution in manufacturing processes, emphasis on cost-effective healthcare access, and overall technological progress.
What Are the Forces Behind the Rapid Growth of the Biosimilar Therapeutic Peptides Market?
Forecasters predict that the rising elderly population will escalate the number of chronic disease patients, fueling the growth of the biosimilar therapeutic peptides market. Older individuals often grapple with an array of chronic illnesses, leading to a swift increase in the global aging population, a trend likely to persist during the projected timeline. The World Health Organization (WHO) suggests that by 2050's close, the global populace aged 60 years and above will probably hit the 2 billion mark. What's more, the World Population Prospects foresees the population aged 80 years and above escalating from 143 million in 2019 to 426 million by 2050. Biosimilar therapeutic peptides find application in the management of various chronic illnesses and cancers. Therefore, the anticipated surge in the older demographic contending with diverse chronic ailments will stimulate the biosimilar therapeutic peptide market's expansion.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp
Who Are the Dominant Companies Influencing Biosimilar Therapeutic Peptides Market Trends?
Major companies operating in the biosimilar therapeutic peptides market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceuticals Co. Ltd., Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, BioXpress Therapeutics SA, Apotex Inc., Teva Pharmaceuticals Industries Ltd., Sandoz International GmbH, Lonza Inc., Stada Arzneimittel AG, Ipsen S.A, Biocon Biopharmaceuticals Pvt. Ltd., Dr. Reddy's Laboratories Ltd., Alvogen Pharma US Inc., Corden Pharma GmbH, Bachem Holding AG, PolyPeptide Laboratories Ltd., PeptiDream Inc., Coherus BioSciences Inc., Celltrion Inc., BioPartners Inc., Samsung Bioepis Co. Ltd.
How Is the Biosimilar Therapeutic Peptides Market Evolving?
Leading firms in the biosimilar therapeutic peptide market are creating a research platform to improve peptide synthesis, increase production efficiency, and guarantee uniform quality, all the way from discovery to commercialization. Many view the Biodrug Design Accelerator as a promising platform for managing research methods for peptide drug discovery, a potential new frontier for drug development. For instance, in May 2023, Fujitsu Limited, a US toy manufacturing and entertainment company, rolled out the Biodrug Design Accelerator platform to expedite research into peptide drug discovery. Through the cycles of design, make, test, analyze (DMTA), the Biodrug Design Accelerator is set to assist pharmaceutical scientists working on peptide drug discovery to speed up and enhance the efficiency of peptide drug development. In addition, it will facilitate the agile and informed creation of peptide drug candidates and foster efficient communication among scientists on synthesis and testing issues.
What Are the Different Segmentations in the Biosimilar Therapeutic Peptides Market?
The biosimilar therapeutic peptides market covered in this report is segmented -
1) By Type: Innovative, Generic
2) By Route Of Administration: Parenteral Route, Transdermal Route, Other Route Of Administrations
3) By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders
Subsegments:
1) By Innovative: Long-Acting Peptides, Combination Peptides
2) By Generic: Monoclonal Antibodies, Hormones, Enzymes
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report
Which Region Is at the Forefront of the Biosimilar Therapeutic Peptides Market?
The countries covered in the biosimilar therapeutic peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
What Is Covered In The Biosimilar Therapeutic Peptides Global Market Report?
- Market Size Analysis: Analyze the Biosimilar Therapeutic Peptides Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Biosimilar Therapeutic Peptides Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Biosimilar Therapeutic Peptides Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Biosimilar Therapeutic Peptides Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3423
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Shaping the Future Biosimilar Therapeutic Peptides Market From 2025-2034: Fujitsu Launches Biodrug Design Accelerator Platform To Revolutionize Peptide Drug Discovery here
News-ID: 3931510 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Peptides
Impact Of Rising Infectious Diseases On Antimicrobial Peptides: A Key Driver Pow …
The Anti Microbial Peptides Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Anti Microbial Peptides Market Size and Its Estimated Growth Rate?
In the past years, there has been significant growth in the anti microbial peptides market size. It is anticipated to…
Applications of Peptides: Unlocking Their Potential
Peptides [https://www.sctsgroup.com/custom-peptide/] are short chains of amino acids that have attracted widespread attention in various fields due to their wide range of applications. Applications of peptides span pharmaceuticals, cosmetics and nutraceuticals, demonstrating their multifaceted benefits. As research continues to develop, the potential of peptides is increasingly recognized.
In the medical field, peptides have particularly promising applications. They are used in drug development, where specific peptides can target disease mechanisms with high…
Antimicrobial Peptides Beyond Traditional Antibiotics: The Antimicrobial Peptide …
Antimicrobial Peptides Market worth $532.02 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Peptides Market - (By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments (Pneumonia, Hepatitis, Bacterial infections, HIV), By Route of Administration (Topical, Subcutaneous, Intravenous), By End User (Pharma and Healthcare, Agriculture Industry,…
What Is The Benefit Of Collagen Peptides?
Who would've guessed that something from bones and skin would become a must-have supplement? We are talking about Collagen. Collagen is being used as powder and capsules as well, or if you are a fan of Organic ways, you can try Bone Broths. It's a protein that works inside your body, and it naturally creates itself inside. The main function of this Collagen in your body is to help your…
Collagen Peptides Market Size And Share
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Collagen Peptides Market was valued at USD 859.24 Million in 2019 and is projected to reach USD 2019.01 Million by 2027, growing at a CAGR of 11.29% from 2020 to 2027.
The collagen peptides market is experiencing robust growth, driven by several key factors. A significant driver is the rising consumer awareness regarding health and wellness, leading to increased demand for dietary supplements and functional foods enriched with…
Peptides Market Current Scenario and Future Prospects
The Peptides Market study with 65+ market data Tables, Pie charts & Figures is now released by HTF MI. The research assessment of the Market is designed to analyze futuristic trends, growth factors, industry opinions, and industry-validated market facts to forecast till 2029. The market Study is segmented by key a region that is accelerating the marketization. This section also provides the scope of different segments and applications that can…
